Skip to content Skip to sidebar Skip to footer
Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug

Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug

An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE), which frequently causes serious infections in hospitalized patients. The study has demonstrated that rifaximin usage is…

Read more

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

Prescriptions of GLP-1RAs and SGLT2 inhibitors in type 1 diabetes patients rose from 2010 to 2023, especially among those with elevated cardiorenal risk. In a recent study published in JAMA Network Open, researchers from the United States of America (US) examined the prescribing trends for glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter…

Read more

the Kick-ass Multipurpose WordPress Theme

© 2025 Kicker. All Rights Reserved.